Número 1 - EII al día

34. McFadden JJ, Butcher PD, Chiodini RJ, Hermon-Taylor J. Determination of
genome size and DNA homology between an unclassified Mycobacterium
species isolated from patients with Crohn’s disease and other mycobacteria.
J Gen Microbiol. 1987;133:211-4.
35. Moss MT, Sanderson JD, Tizard ML, Hermon-Taylor J, el-Zaatari FA, Markesich
DC, et al. Polymerase chain reaction detection of Mycobacterium
paratuberculosis and Mycobacterium avium subsp silvaticum in long term
cultures from Crohn’s disease and control tissues. Gut. 1992;33:1209-13.
36. Lisby G, Andersen J, Engbaek K, Binder V. Mycobacterium paratuberculosis
in intestinal tissue from patients with Crohn’s disease demonstrated
by a nested primer polymerase chain reaction. Scand J Gastroenterol.
1994;29:923-9.
37. Rowbotham DS, Mapstone NP, Trejdosiewicz LK, Howdle PD, Quirke P.
Mycobacterium paratuberculosis DNA not detected in Crohn’s disease tissue
by fluorescent polymerase chain reaction. Gut. 1995;37:660-7.
38. Dumonceau JM, Van Gossum A, Adler M, Fonteyne PA, Van Vooren JP,
Deviere J, et al. No Mycobacterium paratuberculosis found in Crohn’s disease
using polymerase chain reaction. Dig Dis Sci. 1996;41:421-6.
39. Chiba M, Fukushima T, Horie Y, Iizuka M, Masamune O. No Mycobacterium
paratuberculosis detected in intestinal tissue, including Peyer’s
patches and lymph follicles, of Crohn’s disease. J Gastroenterol.
1998;33:482-7.
40. Cellier C, De Beenhouwer H, Berger A, Penna C, Carbonnel F, Parc R, et
al. Mycobacterium paratuberculosis and Mycobacterium avium subsp. silvaticum
DNA cannot be detected by PCR in Crohn’s disease tissue. Gastroenterol
Clin Biol. 1998;22:675-8.
41. Hulten K, El-Zimaity HM, Karttunen TJ, Almashhrawi A, Schwartz MR,
Graham DY, et al. Detection of Mycobacterium avium subspecies paratuberculosis
in Crohn’s diseased tissues by in situ hybridization. Am J Gastroenterol.
2001;96:1529-35.
42. Baksh FK, Finkelstein SD, Ariyanayagam-Baksh SM, Swalsky PA, Klein EC,
Dunn JC. Absence of Mycobacterium avium subsp. paratuberculosis in
the microdissected granulomas of Crohn’s disease. Mod Pathol.
2004;17:1289-94.
43. Autschbach F, Eisold S, Hinz U, Zinser S, Linnebacher M, Giese T, et al.
High prevalence of Mycobacterium avium subspecies paratuberculosis
IS900 DNA in gut tissues from individuals with Crohn’s disease. Gut.
2005;54:944-9.
44. Sechi LA, Scanu AM, Molicotti P, Cannas S, Mura M, Dettori G, et al. Detection
and Isolation of Mycobacterium avium subspecies paratuberculosis
from intestinal mucosal biopsies of patients with and without Crohn’s
disease in Sardinia. Am J Gastroenterol. 2005;100:1529-36.
45. Ellingson JL, Cheville JC, Brees D, Miller JM, Cheville NF. Absence of Mycobacterium
avium subspecies paratuberculosis components from Crohn’s
disease intestinal biopsy tissues. Clin Med Res. 2003;1:217-26.
46. Romero C, Hamdi A, Valentine JF, Naser SA. Evaluation of surgical issue
from patients with Crohn’s disease for the presence of Mycobacterium
avium subspecies paratuberculosis DNA by in situ hybridization and nested
polymerase chain reaction. Inflamm Bowel Dis. 2005;11:116-25.
47. Naser SA, Schwartz D, Shafran I. Isolation of Mycobacterium avium subsp
paratuberculosis from breast milk of Crohn’s disease patients. Am J Gastroenterol.
2000;95:1094-5.
48. Naser SA, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium
avium subspecies paratuberculosis from the blood of patients with Crohn’s
disease. Lancet. 2004;364:1039-44.
49. Freeman H, Noble M. Lack of evidence for Mycobacterium avium subspecies
paratuberculosis in Crohn’s disease. Inflamm Bowel Dis.
2005;11:782-3.
50. Lozano-Leon A, Barreiro-De Acosta M, Domínguez-Muñoz JE. Absence
of Mycobacterium avium subspecies paratuberculosis in Crohn’s disease
patients. Inflamm Bowel Dis. 2006;12.1190-2.
51. Bernstein CN, Blanchard JF, Rawsthorne P, Collins MT. Population-based
case control study of seroprevalence of Mycobacterium paratuberculosis
in patients with Crohn’s disease and ulcerative colitis. J Clin Microbiol.
2004;42:1129-35.
52. Nakase H, Nishio A, Tamaki H, Matsuura M, Asada M, Chiba T, et al. Specific
antibodies against recombinant protein of insertion element 900 of
Mycobacterium avium subspecies paratuberculosis in Japanese patients
with Crohn’s disease. Inflamm Bowel Dis. 2006;12:62-9.
53. Barta Z, Csipo I, Mekkel G, Zeher M, Majoros L. Seroprevalence of Mycobacterium
paratuberculosis in patients with Crohn’s Disease. J Clin Microbiol.
2004;42:5432.
54. Grant IR, O’Riordan LM, Ball HJ, Rowe MT. Incidence of Mycobacterium
paratuberculosis in raw sheep and goats’ milk in England, Wales and Northern
Ireland. Vet Microbiol. 2001;79:123-31.
55. Djonne B, Jensen MR, Grant IR, Holstad G. Detection by immunomagnetic
PCR of Mycobacterium avium subsp. paratuberculosis in milk from
dairy goats in Norway. Vet Microbiol. 2003;92:135-43.
56. Sepulveda AR, Graham DY. Role of Helicobacter pylori in gastric carcinogenesis.
Gastroenterol Clin North Am. 2002;31:517-35.
57. Sartor RB. Does Mycobacterium avium subspecies paratuberculosis cause
Crohn’s disease? Gut. 2005;54:896-8.
58. Russell RK, Satsangi J. IBD: a family affair. Best Pract Res Clin Gastroenterol.
2004;18:525-39.
59. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al.
Association of NOD2 leucine-rich repeat variants with susceptibility to
Crohn’s disease. Nature 2001; 411: 599-603.
60. Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, Podolsky
DK. CARD15/NOD2 functions as an antibacterial factor in human
intestinal epithelial cells. Gastroenterology. 2003;124:993-1000.
61. Bonen DK, Ogura Y, Nicolae DL, Inohara N, Saab L, Tanabe T, et al. Crohn’s
disease-associated NOD2 variants share a signaling defect in response
to lipopolysaccharide and peptidoglycan. Gastroenterology.
2003;124:140-6.
62. Álvarez M, Panés J. CARD15/NOD2 y enfermedad de Crohn. ¿Qué explicaría
su asociación? Enfermedad Inflamatoria Intestinal al Día 2004;3: 8-14.
63. Greenstein RJ. Is Crohn’s disease caused by a mycobacterium? Comparisons
with leprosy, tuberculosis, and Johne’s disease. Lancet Infect Dis.
2003;3:507-14.
64. Lashner BA, Loftus EV Jr. True or false? The hygiene hypothesis for Crohn’s
disease. Am J Gastroenterol. 2006;101:1003-4.
65. Amre DK, Lambrette P, Law L, Krupoves A, Chotard V, Costea F, et al. Investigating
the hygiene hypothesis as a risk factor in pediatric onset Crohn’s disease:
a case-control study. Am J Gastroenterol. 2006 May;101:1005-11.
66. Shanahan F, O’Mahony J. The mycobacteria story in Crohn’s disease. Am
J Gastroenterol. 2005;100:1537-8.
67. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman
WD, et al. Tuberculosis associated with infliximab, a tumor necrosis
factor alpha-neutralizing agent. N Engl J Med. 2001;345:1098-104.
68. Obrador A, Lopez San Roman A, Munoz P, Fortun J, Gassull MA; Grupo
Español de Trabajo de Enfermedad de Crohn y Colitis Ulcerosa (GETEC-
CU). Consensus guideline on tuberculosis and treatment of inflammatory
bowel disease with infliximab. Spanish Working Group on Crohn Disease
and Ulcerative Colitis. Gastroenterol Hepatol. 2003;26:29-33.
69. Naser SA. Mycobacterium in Crohn’s disease is hard to digest. Gastroenterology.
2005;129:1359-60.
16 • Enfermedad Inflamatoria Intestinal al día - Vol. 6 - Nº. 1 - 2007